24 February 2018
News and Views
Links and Services
fiogf49gjkf04August's issue of the Journal of Gastroenterology identifies clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.
Little is known about stopping rules of nuceloside analog treatment for chronic hepatit
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors